U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
4773147731School Climate and Children's Behavioral HealthRecruitingNo Results AvailableConsultation (LLS)|Consultation and Coaching (HLS)Behavioral: Friends for Life|Behavioral: Coping Power Programhttps://ClinicalTrials.gov/show/NCT01941069
4773247732Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to CytomegalovirusActive, not recruitingNo Results AvailableCytomegalovirus Infection|Healthy, no Evidence of DiseaseBiological: multi-CMV epitope modified vaccinia Ankara vaccine|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01941056
4773347733A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant TreatmentCompletedNo Results AvailableMajor Depressive DisorderDrug: CERC-301|Other: Placebohttps://ClinicalTrials.gov/show/NCT01941043
4773447734Complete Lesion Assessment With Fractional ffR and IVUS TechnologYCompletedNo Results AvailablePeripheral Artery Disease|Critical Limb IschemiaDevice: Orbital Atherectomy System|Device: Balloon Angioplastyhttps://ClinicalTrials.gov/show/NCT01941030
4773547735Evaluation of the Ovarian Reserve in Infertile Patients With EndometriosisCompletedNo Results AvailableEndometriosishttps://ClinicalTrials.gov/show/NCT01941017
4773647736Safety and Efficacy of Fingolimod in MS Patients in ChinaWithdrawnNo Results AvailableMultiple Sclerosis (Relapsing Remitting)Drug: fingolimod|Drug: Placebo (6mos) + open label fingolimod (6 mos)https://ClinicalTrials.gov/show/NCT01941004
4773747737Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet LinesCompletedNo Results AvailableSkin AgingDrug: Placebo|Drug: Botulinum Toxin Type Ahttps://ClinicalTrials.gov/show/NCT01940991
4773847738A Study of Combination Therapy in Children With ADHDCompletedNo Results AvailableADHD|Attention Deficit Hyperactivity Disorder|Attention Deficit Disorder With Hyperactivity|Mental Disorders Diagnosed in Childhood|Attention Deficit and Disruptive Behavior DisordersDrug: Methylphenidate ER|Drug: Cyproheptadinehttps://ClinicalTrials.gov/show/NCT01940978
4773947739Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 DiabetesCompletedNo Results AvailableType 2 Diabetes MellitusDrug: lixisenatide AVE0010|Drug: biguanide|Drug: TZD|Drug: alpha-GI|Drug: glinidehttps://ClinicalTrials.gov/show/NCT01940965
4774047740Zydena on Cognitive Function of Alzheimer's Disease PatientsNot yet recruitingNo Results AvailableAlzheimer's DiseaseDrug: Zydena (Udenafil) 50mg + Donepezil 5mg or 10mg|Drug: Placebo + Donepezil 5mg or 10mg|Drug: Zydena (Udenafil) 100mg + Donepezil 5mg or 10mghttps://ClinicalTrials.gov/show/NCT01940952
4774147741A Randomized Double-blind Controlled Study of Repetitive Transcranial Magnetic Stimulation for the Treatment of Cognitive Impairment Such as Working Memory in SchizophreniaRecruitingNo Results AvailableSchizophreniaDevice: Repetitive Transcranial Magnetic Stimulationhttps://ClinicalTrials.gov/show/NCT01940939
477424774268Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid ArthritisRecruitingNo Results AvailableRheumatoid ArthritisDrug: 68Ga-BNOTA-PRGD2https://ClinicalTrials.gov/show/NCT01940926
4774347743Efficacy and Safety of a Probiotic Product in Children With Antibiotic-associated Gastrointestinal Disorders.CompletedNo Results AvailableAntibiotic-associated Loose/Watery StoolsDietary Supplement: Probiotic capsules|Dietary Supplement: Placebo capsuleshttps://ClinicalTrials.gov/show/NCT01940913
4774447744A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® MonotherapyActive, not recruitingNo Results AvailableAge-Related Macular DegenerationDrug: E10030|Drug: ranibizumab|Drug: E10030 sham intravitreal injectionhttps://ClinicalTrials.gov/show/NCT01940900
4774547745A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® MonotherapyRecruitingNo Results AvailableAge-Related Macular DegenerationDrug: E10030|Drug: bevacizumab or aflibercept|Drug: E10030 sham intravitreal injectionhttps://ClinicalTrials.gov/show/NCT01940887
4774647746Cerebral Oxymetry at Elective Coronary and Valve Surgery.CompletedNo Results AvailableCoronary Artery Disease.|Aortic Valve Stenosis.|Aortic Valve Regurgitation.https://ClinicalTrials.gov/show/NCT01940874
4774747747Cerebral Oxymetry in Traumatic Brain InjuryRecruitingNo Results AvailableTraumatic Brain Injuryhttps://ClinicalTrials.gov/show/NCT01940861
4774847748Efficacy/Safety Study to Confirm Iberogast's Efficacy in Rome-III Patients in Irritable Bowel SyndromeRecruitingNo Results AvailableIrritable Bowel SyndromeDrug: STW5 (Iberogast, BAY98-7411)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01940848
4774947749Role of Intestinal Inflammation in the Pathogenesis of Type 1 DiabetesRecruitingNo Results AvailableType 1 DiabetesProcedure: Upper endoscopy with small bowel biopsies and brushings.|Other: Blood draw|Other: Stool samplehttps://ClinicalTrials.gov/show/NCT01940835
4775047750Cardiovascular Effects of Energy Drinks in Healthy AdultsRecruitingNo Results AvailableEnergy Drinks|Hemodynamics|Cardiovascular SystemOther: Energy Drink|Other: Placebo Drinkhttps://ClinicalTrials.gov/show/NCT01940822
4775147751Ipilimumab With or Without Dabrafenib, and/or Trametinib in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by SurgeryRecruitingNo Results AvailableStage IIIA Skin Melanoma|Stage IIIB Skin Melanoma|Stage IIIC Skin Melanoma|Stage IV Skin MelanomaDrug: Dabrafenib|Biological: Ipilimumab|Other: Laboratory Biomarker Analysis|Drug: Trametinibhttps://ClinicalTrials.gov/show/NCT01940809
4775247752Phase I Trial of Brentuximab Vedotin for Refractory Chronic Graft-vs.-Host Disease (GVHD)RecruitingNo Results AvailableGraft-vs-Host Disease|GVHDDrug: Brentuximab Vedotinhttps://ClinicalTrials.gov/show/NCT01940796
4775347753Assessment of the AB HiFocusTM Mid Scala Electrode Movement Using Cone Beam Imaging Following Cochlea ImplantationRecruitingNo Results AvailableCochlear Implantation|Cone-Beam Computed TomographyRadiation: Cone Beam Computed Tomography (CBCT)|Device: Magnetic Resonance Imaging (MRI)https://ClinicalTrials.gov/show/NCT01940783
4775447754Specific Clinical Experience Investigation for Long-term Use of BydureonRecruitingNo Results AvailableType 2 Diabeteshttps://ClinicalTrials.gov/show/NCT01940770
4775547755Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm LarvaeRecruitingNo Results AvailableHookworm InfectionBiological: Necator americanus Hookworm Larvaehttps://ClinicalTrials.gov/show/NCT01940757
4775647756Prescriptive Mobilization Versus a Pragmatic MobilizationRecruitingNo Results AvailableMechanical Low Back PainProcedure: Prescriptive Mobilization|Procedure: Pragmatic Mobilizationhttps://ClinicalTrials.gov/show/NCT01940744
4775747757Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in AdultsNot yet recruitingNo Results AvailableHospital-acquired PneumoniaDrug: Colistimethate sodiumhttps://ClinicalTrials.gov/show/NCT01940731
4775847758Androgen Regulation of Priapism in Sickle Cell DiseaseNot yet recruitingNo Results AvailablePriapism|Sickle Cell DiseaseDrug: Transdermal Androgelhttps://ClinicalTrials.gov/show/NCT01940718
4775947759A Simplified Patient-Centered Educational Tool for Improved Hearing-Aid OutcomesRecruitingNo Results AvailableHearing LossOther: Hearing-Aid Informational Guide|Other: Hearing-Aid DVD|Behavioral: Teach-back Technique|Other: Standard of Carehttps://ClinicalTrials.gov/show/NCT01940705
4776047760Topical Application of TXA Compared to the IV Administration in THA With the DAAActive, not recruitingNo Results AvailableOsteoarthrosisDrug: 1.5g intravenous Exacyl|Drug: 3.0g intra-articular Exacylhttps://ClinicalTrials.gov/show/NCT01940692

* Görseller ve İçerik tekif hakkına sahip olabilir